20031681

Source:http://linkedlifedata.com/resource/pubmed/id/20031681

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0439234, umls-concept:C0549178, umls-concept:C1322815, umls-concept:C1554184
pubmed:issue	3
pubmed:dateCreated	2009-12-24
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20031681-20031682
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101499602
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine, http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1941-7632
pubmed:author	pubmed-author:BhattDeepak LDL, pubmed-author:ChhatriwallaAdnan KAK
pubmed:issnType	Electronic
pubmed:volume	1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	217-25
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20031681-Acute Coronary Syndrome, pubmed-meshheading:20031681-Angioplasty, Balloon, Coronary, pubmed-meshheading:20031681-Aspirin, pubmed-meshheading:20031681-Coronary Restenosis, pubmed-meshheading:20031681-Coronary Thrombosis, pubmed-meshheading:20031681-Drug Therapy, Combination, pubmed-meshheading:20031681-Drug-Eluting Stents, pubmed-meshheading:20031681-Hemorrhage, pubmed-meshheading:20031681-Humans, pubmed-meshheading:20031681-Myocardial Infarction, pubmed-meshheading:20031681-Patient Selection, pubmed-meshheading:20031681-Platelet Aggregation Inhibitors, pubmed-meshheading:20031681-Ticlopidine, pubmed-meshheading:20031681-Time Factors
pubmed:year	2008
pubmed:articleTitle	Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
pubmed:affiliation	Division of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
pubmed:publicationType	Journal Article